United Therapeutics (FRA:UTH) Forward PE Ratio : 10.22 (As of Apr. 28, 2024)

View and export this data going back to . Start your Free Trial

What is United Therapeutics Forward PE Ratio?

United Therapeutics's Forward PE Ratio for today is 10.22.

United Therapeutics's PE Ratio without NRI for today is 11.79.

United Therapeutics's PE Ratio for today is 11.79.

United Therapeutics Forward PE Ratio Historical Data

The historical data trend for United Therapeutics's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Forward PE Ratio Chart

United Therapeutics Annual Data

Trend

2015-12

2016-12

2017-12

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-04

Forward PE Ratio

12.97

8.87

12.85

10.94

8.70

11.93

11.56

14.18

9.70

10.36

United Therapeutics Quarterly Data
	2015-12	2016-03	2016-06	2016-09	2016-12	2017-03	2017-06	2017-09	2017-12	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03
Forward PE Ratio	12.97	7.22	8.04	8.15	8.87	9.20	8.83	10.83	12.85	8.70	8.94	12.39	10.94	11.00	7.51	8.61	8.70	8.05	10.71	9.67	11.93	12.30	13.46	11.76	11.56	10.40	15.38	11.24	14.18	11.25	12.32	10.55	9.70	10.45

Competitive Comparison of United Therapeutics's Forward PE Ratio

For the Biotechnology subindustry, United Therapeutics's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Therapeutics's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, United Therapeutics's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where United Therapeutics's Forward PE Ratio falls into.

United Therapeutics Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

United Therapeutics (FRA:UTH) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

United Therapeutics Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics (FRA:UTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (FRA:UTH) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

UTHR:USA UTH:Germany

Address

1040 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (FRA:UTH) Headlines

No Headlines